We are live on
!
Find out more
UOC
UBS O'Connor Portfolio holdings
AUM
$3.76B
1-Year Est. Return
62.41%
This Fund
S&P 500
This Quarter
Est. Return
+3.87%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$4.81B
AUM Growth
-$531M
(-9.9%)
Cap. Flow
-$1.24B
Cap. Flow
% of AUM
-25.85%
Top 10 Holdings %
Top 10 Hldgs %
18.16%
Holding
673
New
167
Increased
91
Reduced
97
Closed
256
Avg Time Held Equity + Options
0.6
quarters
Top 10 Avg Time Held Equity + Options
0.6
quarters
Top 20 Avg Time Held Equity + Options
0.4
quarters
Avg Time Held Equity only
0.6
quarters
Top 10 Avg Time Held Equity only
0.6
quarters
Top 20 Avg Time Held Equity only
0.4
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Colgate-Palmolive
CL
|
+$59.4M |
| 2 |
ONXX
ONYX PHARMACEUTICALS INC
ONXX
|
+$56.3M |
| 3 |
Simon Property Group
SPG
|
+$52M |
| 4 |
TSMC
TSM
|
+$45.4M |
| 5 |
Macy's
M
|
+$44.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$167M |
| 2 |
GDI
GARDNER DENVER,INC
GDI
|
+$60.4M |
| 3 |
BMC
BMC SOFTWARE, INC
BMC
|
+$58.7M |
| 4 |
SMITHFIELD FOODS,INC
SFD
|
+$55.2M |
| 5 |
Advance Auto Parts
AAP
|
+$48.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 29.53% |
| 2 | Real Estate | 16.41% |
| 3 | Consumer Staples | 12.46% |
| 4 | Financials | 6.75% |
| 5 | Consumer Discretionary | 6.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
476
Pfizer
PFE
$161B
| – | – |
-6,269,077
| Closed | -$167M | – |
|
|
477
PUT
Pfizer
PFE
$161B
| – | – |
-6,062,081
| Closed | -$40M | – |
|
478
PhenixFIN
PFX
$86.8M
| – | – |
-16,476
| Closed | -$4.47M | – |
|
479
Post Holdings
POST
$3.39B
| – | – |
-789,889
| Closed | -$22.6M | – |
|
480
PPG Industries
PPG
$23.1B
| – | – |
-132,906
| Closed | -$9.73M | – |
|
481
abrdn Physical Platinum Shares ETF
PPLT
$2.01B
| – | – |
-40,000
| Closed | -$524K | – |
|
482
CALL
Patterson-UTI
PTEN
$4.31B
| – | – |
-50,000
| Closed | -$5K | – |
|
483
BCP Investment Corp
BCIC
$85.8M
| – | – |
-59,069
| Closed | -$6.65M | – |
|
484
Regeneron Pharmaceuticals
REGN
$76.9B
| – | – |
-8,900
| Closed | -$2M | – |
|
485
Reliance Steel & Aluminium
RS
$20.5B
| – | – |
-105,933
| Closed | -$6.95M | – |
|
486
Revvity
RVTY
$17.2B
| – | – |
-12,212
| Closed | -$397K | – |
|
487
PUT
Charles Schwab
SCHW
$167B
| – | – |
-180,900
| Closed | -$95K | – |
|
488
Tanger
SKT
$4.03B
| – | – |
-95,275
| Closed | -$3.19M | – |
|
489
SLB Ltd
SLB
$72.6B
| – | – |
-339,326
| Closed | -$24.3M | – |
|
|
490
PUT
SLB Ltd
SLB
$72.6B
| – | – |
-12,800
| Closed | -$2K | – |
|
491
SL Green Realty
SLG
$3.43B
| – | – |
-174,226
| Closed | -$14.9M | – |
|
492
Sonoco
SON
$4.74B
| – | – |
-301,580
| Closed | -$10.4M | – |
|
493
CALL
State Street SPDR S&P 500 ETF Trust
SPY
$822B
| – | – |
-1,640,000
| Closed | -$1.79M | – |
|
494
CALL
Sempra
SRE
$53.2B
| – | – |
-100,000
| Closed | -$12K | – |
|
495
SS&C Technologies
SSNC
$19B
| – | – |
-26,066
| Closed | -$429K | – |
|
496
Starwood Property Trust
STWD
$4.7B
| – | – |
-138,057
| Closed | -$2.75M | – |
|
497
Skyworks Solutions
SWKS
$11.5B
| – | – |
-19,016
| Closed | -$416K | – |
|
498
Teck Resources
TECK
$33.4B
| – | – |
-350,002
| Closed | -$7.48M | – |
|
499
PUT
Target
TGT
$69.8B
| – | – |
-103,500
| Closed | -$187K | – |
|
500
iShares 20+ Year Treasury Bond ETF
TLT
$48.5B
| – | – |
-85,000
| Closed | -$9.01M | – |
|
Similar funds
FNBT
ACI
RC
A
CGL
CB
JCM
MPM
UBS O'Connor's Q3 2013 Portfolio in Review
As of Q3 2013, UBS O'Connor held 673 positions worth $4.81B, down 9.9% from $5.34B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
UBS O'Connor withdrew a net $1.24B in Q3 2013, closing 256 positions and reducing 97 holdings. Its most notable exit was Pfizer, an estimated $167M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 30% of assets, up from 27% a quarter earlier, followed by Real Estate and Consumer Staples.
Against the trend, UBS O'Connor opened a new position in Colgate-Palmolive worth $59.4M.
- UBS O'Connor's largest Q3 2013 buy was Colgate-Palmolive: 1,002,498 shares worth $59.4M.
- UBS O'Connor added most to ONYX PHARMACEUTICALS INC in Q3 2013, an estimated $56.3M increase.
- UBS O'Connor's biggest Q3 2013 reduction was Advance Auto Parts, cutting an estimated $48.2M.
- UBS O'Connor fully exited Pfizer in Q3 2013, selling an estimated $167M.
- UBS O'Connor's ten largest holdings make up 18% of its $4.81B portfolio in Q3 2013.
- UBS O'Connor opened 167 new positions and closed 256 in Q3 2013.
- UBS O'Connor's portfolio value fell 9.9% quarter-over-quarter to $4.81B.
Based on UBS O'Connor's 13F filing for Q3 2013, filed 14 Nov 2013.